Sharps Technology, Inc. (STSS) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Melville, NY, United States. The current CEO is Paul Kruger Danner.
STSS has IPO date of 2022-04-14, 55 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $44.4M.
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
